Upadacitinib, a drug used to treat atopic dermatitis (AD), may potentially induce alopecia areata, a case study suggests.

Posters at AMCP Nexus analyzed the burden of flares on patients with atopic dermatitis (AD) and the impact initiating ...

The following is a summary of “Single cell sequencing delineates T-cell clonality and pathogenesis of the parapsoriasis ...

ZORYVE foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved in Canada in over two ...

Results of a retrospective real-world study suggested no greater risk for major CV adverse events in patients treated with ...

The global canine atopic dermatitis treatment market is projected to witness substantial growth over the next decade, with a ...

COLLODIAL OATMEAL HAS anti-inflammatory and antioxidant properties that benefit the skin in a variety of ways, Dr. Lio says.

This article explores how seborrheic dermatitis impacts Black Americans and why the condition may manifest differently in ...

Seborrheic dermatitis can be a frustrating and persistent skin condition. Whether it's the red, flaky patches on your scalp ...

Eczema is a prevalent skin condition that affects millions of people, characterized by red, dry and itchy patches on the skin ...

A global team of researchers at the Max Planck Institute of Biochemistry has made a groundbreaking discovery that saves the lives of patients suffering from toxic epidermal necrolysis.